CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Dose KRAS Mutation Status Affect on the Effect of VEGF Therapy in Metastatic Colon Cancer Patients?
Seung Tae Kim, Kyong Hwa Park, Sang Won Shin, Yeul Hong Kim
Cancer Research and Treatment. 2014;46(1):48-54.   Published online 2014 January 15    DOI: https://doi.org/10.4143/crt.2014.46.1.48

Excel Download

Dose KRAS Mutation Status Affect on the Effect of VEGF Therapy in Metastatic Colon Cancer Patients?
Cancer Research and Treatment. 2014;46(1):48-54   Crossref logo
Link1 Link2

Impact of KRAS Mutation Status on Outcomes in Metastatic Colon Cancer Patients without Anti-Epidermal Growth Factor Receptor Therapy
Cancer Research and Treatment. 2013;45(1):55-62   Crossref logo
Link1 Link2

6136 POSTER Relatively High Discordant Rate of KRas Mutation Between Primary and Metastatic Sites, and a Different Pattern of KRas Mutational Status According to Metastatic Sites in Korean Patients With Colorectal Cancer
European Journal of Cancer. 2011;47:S433   Crossref logo
Link1 Link2

Circulating regulatory T-cells and the clinical outcome of VEGF-targeted treatment of metastatic colorectal cancer patients: focused on KRAS status and primary tumour sidedness
European Journal of Cancer. 2018;92:S1-S2   Crossref logo
Link1 Link2

Implications of KRAS mutation status for the treatment of metastatic colorectal cancer
Targeted Oncology. 2009;4(4):311-322   Crossref logo
Link1 Link2 Link3

The effect of anti-VEGF drugs (bevacizumab and aflibercept) on the survival of patients with metastatic colorectal cancer (mCRC)
OncoTargets and Therapy. 2012;59   Crossref logo
Link1

Comparison of Kras Mutation Status Between Primary Tumors and Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer (MCRC)
Annals of Oncology. 2013;24:iv25   Crossref logo
Link1 Link2 Link3

Panitumumab – an effective long-term treatment for patients with metastatic colorectal cancer and wild-type KRAS status
Cancer Treatment Reviews. 2010;36:S15-S16   Crossref logo
Link1 Link2

KRAS Status as a Predictor of Chemotherapy Activity in Patients With Metastatic Colorectal Cancer
Clinical Colorectal Cancer. 2019;18(4):e309-e315   Crossref logo
Link1 Link2

Hormone Receptor Status Does Not Affect the Clinical Benefit of Trastuzumab Therapy for Patients with Metastatic Breast Cancer
Clinical Breast Cancer. 2005;6(3):247-252   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.